Electrical substance clearance from the brain
AssigneeRainbow Medical Ltd.
InventorsGideon Fostick, Yossi Gross, Alex Tendler
Life of this patent
Estimating the term…
Loading patent…
AssigneeRainbow Medical Ltd.
InventorsGideon Fostick, Yossi Gross, Alex Tendler
Estimating the term…
A method is provided that includes implanting a first electrode in a cerebrospinal fluid (CSF)-filled space of a brain of a subject identified as at risk of or suffering from Alzheimer's disease. One or more second electrodes are implanted superficial to brain parenchyma of the subject, such that the brain parenchyma is spatially disposed between a ventricular system of the brain and the one or more second electrodes. Control circuitry is activated to drive the first and the one or more second electrodes to clear amyloid beta and/or tau protein from the brain parenchyma into the ventricular system by applying current between the first electrode and the one or more second electrodes using an average voltage of less than 1.2 V. Other embodiments are also described.
A method comprising:
Apparatus comprising:
Dependencies are inferred from the claim text.